Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973;136:602–606.
-
2.
Khoury MD, Lloyd LR, Burrows J. A totally implanted venous access system for the delivery of chemotherapy. Cancer 1985;56:1231–1234.
-
3.
Newman KA, Reed WP & Bustamante CI, et al. Venous access devices utilized in association with intensive cancer chemotherapy. Eur J Cancer Clin Oncol 1989;25:1375–1378.
-
4.
Ingram J, Weitzman S & Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991;13:130–136.
-
5.
Sabel MS, Smith JL. Principles of chronic venous access: recommendations based on the Roswell Park experience. Surg Oncol 1998;6:171–177.
-
6.
Dalton MJ. The vascular port: a subcutaneously implanted drug delivery depot. Lab Anim 1985;14:21–30.
-
7.
Lokich JJ, Bothe A & Benotti P, et al. Complications and management of implanted venous access catheters. J Clin Oncol 1985;3:710–717.
-
8.
Minassian VA, Sood AK & Lowe P, et al. Longterm central venous access in gynecologic cancer patients. J Am Coll Surg 2000;191:403–409.
-
9.
Adler A, Yaniv I & Steinber R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358–365.
-
10.
Niederhuber JE, Ensminger W & Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706–712.
-
11.
Strum S, McDermed J & Korn A, et al. Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system. J Clin Oncol 1986;4:596–603.
-
12.
Gyves JW, Ensminger WD & Niederhuber JE, et al. A totally implanted injection port system for blood sampling and chemotherapy administration. JAMA 1984;251:2538–2541.
-
13.
Sariego J, Bootorabi B, Matsumoto T. Major long-term complications in 1,422 permanent venous access devices. Am J Surg 1993;165:249–251.
-
14.
Hartkamp A, van Boxtel AJH & Zonnenberg BA, et al. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems. Neth J Med 2000;57:215–223.
-
15.
Perry-Clark LM, Meunier LD. Vascular access ports for chronic serial infusion and blood sampling in New Zealand white rabbits. Lab Anim Sci 1991;41:495–497.
-
16.
Wojnicki FHE, Bacher JD, Glowa JR. Use of subcutaneous vascular access ports in Rhesus monkeys. Lab Anim Sci 1994;44:491–494.
-
17.
Webb AI, Bliss JM, Herbst LH. Use of vascular access ports in the cat. Lab Anim Sci 1995;45:110–114.
-
18.
Cowart RP, Payne JT & Turk JR, et al. Factors optimizing the use of subcutaneous vascular access ports in weaned pigs. Contemp Top Lab Anim Sci 1999;38:67–70.
-
19.
Henderson KK, Mokelke EA & Turk JR, et al. Maintaining patency and asepsis of vascular access ports in Yucatan miniature swine. Contemp Top Lab Anim Sci 2003;42:28–32.
-
20.
Chuang M, Orvieto M & Laven B, et al. Comparison of external catheters with subcutaneous vascular access ports for chronic vascular access in a porcine model. Contemp Top Lab Anim Sci 2005;44:24–27.
-
21.
Ege CA, Parra NC, Johnson TE. Noninfectious complications due to vascular access ports (VAPs) in Yucatan minipigs (Sus scrofa domestica). Lab Anim Sci 2006;45:27–34.
-
22.
Mayer MN, Grier CK & Yoshikawa H, et al. Complications associated with the use of vascular access ports in dogs receiving external beam radiation therapy. J Am Vet Med Assoc 2008;233:96–103.
-
23.
Evans KL, Smeak DD & Couto CG, et al. Comparison of two indwelling central venous access catheters in dogs undergoing fractionated radiotherapy. Vet Surg 1994;23:135–142.
-
24.
Henry CJ, Russel LE & Tyler JW, et al. Comparison of hematologic and biochemical values for blood samples obtained via jugular venipuncture and via vascular access ports in cats. J Am Vet Med Assoc 2002;220:482–485.
-
25.
Cahalane AK, Rassnick KM, Flanders JA. Use of vascular access ports in femoral veins of dogs and cats with cancer. J Am Vet Med Assoc 2007;231:1354–1360.
-
26.
Morrison JA, Lauer SK & Baldwin CJ, et al. Evaluation of the use of subcutaneous implantable vascular access ports in feline blood donors. J Am Vet Med Assoc 2007;230:855–861.
-
27.
Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients. Cancer 1997;79:1635–1640.
-
28.
Blaiset MA, Couto CG & Evans KL, et al. Complications of indwelling, silastic central venous access catheters in dogs and cats. J Am Anim Hosp Assoc 1995;31:379–384.
-
29.
Cohn DE, Mutch DG & Rader JS, et al. Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies. Gynecol Oncol 2001;83:533–536.
-
30.
Ignatov A, Hoffman O & Smith B, et al. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. Eur J Surg Oncol 2008;35:241–246.
-
31.
Biagi E, Arrigo C & Dell'Orto MG, et al. Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies. Support Care Cancer 1997;5:228–233.
-
32.
Samaras P, Dold S & Braun J, et al. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology 2008;74:237–244.
-
33.
Sano T, Nishimura R & Mochizuki M, et al. Clinical usefulness of propofol as an anesthetic induction agent in dogs and cats. J Vet Med Sci 2003;65:641–643.
-
34.
Bley CR, Roos M & Price J, et al. Clinical assessment of repeated propofol-associated anesthesia in cats. J Am Vet Med Assoc 2007;231:1347–1353.
Advertisement
Complications associated with use of subcutaneous vascular access ports in cats and dogs undergoing fractionated radiotherapy: 172 cases (1996–2007)
Abstract
Objective—To describe complications associated with use of a subcutaneous vascular access port (SVAP) in cats and dogs treated with fractionated radiotherapy and to determine predisposing factors for developing these complications.
Design—Retrospective case series.
Animals—46 cats and 126 dogs.
Procedures—The medical records of cats and dogs undergoing radiation therapy that received placement of an SVAP between March 1996 and August 2007 were reviewed. Data were recorded and analyzed to determine factors for development of complications associated with the use of an SVAP during treatment with fractionated radiotherapy.
Results—18 and 36 major and minor complications were identified, respectively. Sex and the lack of administration of propofol during anesthesia induction were significantly associated with development of major complications. Female cats and dogs were 5.00 times as likely as male cats and dogs to develop major complications associated with SVAP usage. Animals in which propofol was not administered were 19.15 times as likely as animals administered propofol to develop major complications. Placement of SVAP catheters in a femoral vein was 17.20 times as likely as placement in the jugular vein to result in minor complications.
Conclusions and Clinical Relevance—Factors associated with the development of complications included sex, propofol administration, and vein in which an SVAP catheter was inserted. The use of an SVAP may be a useful alternative to repeated catheterizations in cats and dogs.
Contributor Notes
Dr. Culp's present address is Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
Dr. Mayhew's present address is Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
Dr. Glassman's present address is Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Presented in abstract form at the Veterinary Cancer Society Meeting, Seattle, October 2008.
Powered by PubFactory